Charlotte's Web Serves as a Premier CBD Partner for Landmark Medicare and Medicaid Pilot Program

Core Insights - The pilot program by the Center for Medicare and Medicaid Innovation (CMMI) allows senior cancer patients to access science-backed CBD products with Medicare and Medicaid reimbursement, marking a significant shift in senior healthcare policy [1][3] - Charlotte's Web Holdings, Inc. will provide a range of products tailored for oncology patients through a secure online healthcare portal, enhancing accessibility and personalization in treatment [2][3] - The initiative aims to reduce out-of-pocket costs for seniors, addressing a critical gap in supportive care and making CBD more affordable for low-income Americans [3] Company Initiatives - Charlotte's Web will launch products for oncology patients in early 2026, utilizing an eCommerce platform that ensures data security for patients and healthcare providers [2] - The company emphasizes scientific rigor and clinical validation in its product offerings, supported by a Scientific Advisory Board that guides the program [4][5] - Realm of Caring, a nonprofit organization, will assist in providing education and support for patients and healthcare providers, capturing real-world data to inform future research [6][7] Market Context - There are approximately 67 million Medicare beneficiaries in the U.S., with nearly 20% of seniors using CBD for various age-related conditions, highlighting the potential market for CBD products [3] - The pilot program represents a new model of care that integrates evidence-based, patient-centered CBD healthcare delivery, aiming to improve overall patient outcomes [8][9] - Charlotte's Web's commitment to quality and consistency positions it as a leader in the CBD market, with ongoing research and development to expand therapeutic applications [10][9]